Halozyme Therapeutics Inc (HALO)
58.48
+1.33
(+2.33%)
USD |
NASDAQ |
Nov 04, 16:00
58.67
+0.19
(+0.32%)
After-Hours: 20:00
Halozyme Therapeutics Enterprise Value: 8.109B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 8.109B |
| October 31, 2024 | 7.272B |
| October 30, 2024 | 7.274B |
| October 29, 2024 | 7.281B |
| October 28, 2024 | 7.258B |
| October 25, 2024 | 7.104B |
| October 24, 2024 | 7.110B |
| October 23, 2024 | 7.299B |
| October 22, 2024 | 7.394B |
| October 21, 2024 | 7.422B |
| October 18, 2024 | 7.529B |
| October 17, 2024 | 7.487B |
| October 16, 2024 | 7.637B |
| October 15, 2024 | 7.683B |
| October 14, 2024 | 7.699B |
| October 11, 2024 | 7.579B |
| October 10, 2024 | 7.468B |
| October 09, 2024 | 7.281B |
| October 08, 2024 | 7.722B |
| October 07, 2024 | 7.687B |
| October 04, 2024 | 8.365B |
| October 03, 2024 | 8.524B |
| October 02, 2024 | 8.235B |
| October 01, 2024 | 8.041B |
| September 30, 2024 | 8.118B |
| Date | Value |
|---|---|
| September 27, 2024 | 8.190B |
| September 26, 2024 | 8.188B |
| September 25, 2024 | 8.051B |
| September 24, 2024 | 8.093B |
| September 23, 2024 | 8.388B |
| September 20, 2024 | 8.478B |
| September 19, 2024 | 8.511B |
| September 18, 2024 | 8.867B |
| September 17, 2024 | 8.819B |
| September 16, 2024 | 8.943B |
| September 13, 2024 | 8.866B |
| September 12, 2024 | 8.643B |
| September 11, 2024 | 8.497B |
| September 10, 2024 | 8.480B |
| September 09, 2024 | 8.478B |
| September 06, 2024 | 8.474B |
| September 05, 2024 | 8.707B |
| September 04, 2024 | 8.844B |
| September 03, 2024 | 8.729B |
| August 30, 2024 | 9.062B |
| August 29, 2024 | 9.048B |
| August 28, 2024 | 9.134B |
| August 27, 2024 | 8.980B |
| August 26, 2024 | 8.848B |
| August 23, 2024 | 8.919B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.900B
Minimum
Mar 18 2020
9.276B
Maximum
Dec 02 2022
5.801B
Average
5.979B
Median
Enterprise Value Benchmarks
| Azenta Inc | 1.420B |
| OraSure Technologies Inc | 43.57M |
| Insulet Corp | 17.10B |
| Myomo Inc | 104.06M |
| TransMedics Group Inc | 2.944B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 137.01M |
| Revenue (Quarterly) | 290.08M |
| Total Expenses (Quarterly) | 126.89M |
| EPS Diluted (Quarterly) | 1.05 |
| Gross Profit Margin (Quarterly) | 82.96% |
| Profit Margin (Quarterly) | 47.23% |
| Earnings Yield | 5.16% |
| Operating Earnings Yield | 6.28% |
| Normalized Earnings Yield | 4.929 |